搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
emjreviews.com
15 小时
Optimizing Salvage Therapy for Pediatric Hodgkin Lymphoma
A new study explores PET-guided risk stratification to tailor salvage therapy in pediatric relapsed/refractory Hodgkin ...
Cure Today
1 天
Understanding the Intricacies of CAR-T Cell Therapy and Care in Hematologic Malignancies
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...
emjreviews.com
1 天
CAR-T Cell Therapy Shows Promise for Transformed Indolent Non-Hodgkin Lymphoma
A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients ...
1 天
Award for teen who used cancer diagnosis as springboard to help others
An inspirational 14-year-old who used her cancer diagnosis as a springboard to support other young patients, has been recognised by HRH The Duke ...
3 天
Navi Mumbai: 39-Year-Old Corporate Professional Wins Battle Against Aggressive Lymphoma ...
Navi Mumbai: In a medical breakthrough at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, a 39-year-old Rijesh Nair, a ...
3 天
Man shares symptoms he noticed that led him to being diagnosed with stage four cancer aged 19
A 19-year-old has shared the pre-cancer symptoms he noticed prior to being diagnosed with with stage four Hodgkin lymphoma.
The Lancet
4 天
The challenges of detecting early efficacy signals in lymphoma trials
Follicular lymphoma is considered an indolent disease, with long-term tumour control achieved by first-line ...
Cure Today
4 天
CAR T-Cell Therapy Yescarta Continues to Demonstrate Durable Responses in Follicular Lymphoma
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma.
The American Journal of Managed Care
4 天
New Generation of CAR T May Elicit Improved CR Rates in CLL
T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...
Managed Healthcare Executive
4 天
Tafasitamab Shows Promising Results in Follicular Lymphoma Phase 3 Trial
Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.
Too Old to Operate
4 天
ZUMA-5: Curative Potential of Axi-Cel in Follicular Lymphoma
Axicabtagene ciloleucel had durable responses, long-term survival, and consistent outcomes in patients with relapsed or ...
unilad
4 天
Woman reveals three symptoms she ignored before being diagnosed with stage 4 cancer at 28
Georgie Swallow was just 28-years-old when she received the devastating news that she had stage 4 Hodgkin lymphoma ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈